Philip Vitale - IsoRay Independent Director
ISRDelisted Stock | USD 0.38 0.01 2.70% |
Director
Dr. Philip J. Vitale, M.D., is a Independent Director of IsoRay, Inc., since 2014. Dr. Vitale was also an Assistant Professor at the University of New Mexico, Division of Urology. He is a member of the American Urological Association and the South Central Section of the American Urological Association. Prior to his retirement, Dr. Vitales clinical trials included chemotherapy after prostatectomy a phase III randomized study for high risk prostate carcinoma RTOG 0415 a phase III randomized study of hypofractionated 3dcrtIMRT versus conventionally fractionated 3dcrtIMRT in patients with favorablerisk prostate cancer RTOG 0815 a phase III prospective randomized trial of doseescalated radiotherapy with or without shortterm androgen deprivation therapy for patients with intermediaterisk prostate cancer and YP19A1 gene and pharmacogenetics of response to testosterone therapy. Dr. Vitale holds a B.A. in Biology from LaSalle College and obtained his M.D. from the New Jersey College of Medicine and Dentistry. He received his M.S. in Health Services Administration from the College of St. Francis. Dr. Vitale brings to the Board medical expertise in the industries the Company is targeting. since 2014.
Age | 72 |
Tenure | 10 years |
Phone | 509 375 1202 |
Web | https://isoray.com |
IsoRay Management Efficiency
The company has Return on Asset of (0.1085) % which means that on every $100 spent on assets, it lost $0.1085. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.1741) %, meaning that it generated no profit with money invested by stockholders. IsoRay's management efficiency ratios could be used to measure how well IsoRay manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Found 2 records | DIRECTOR Age | ||
Rakesh Patel | Evertz Technologies Limited | 51 | |
Scott Galit | Payoneer Global | 54 |
Management Performance
Return On Equity | -0.17 | |||
Return On Asset | -0.11 |
IsoRay Inc Leadership Team
Elected by the shareholders, the IsoRay's board of directors comprises two types of representatives: IsoRay inside directors who are chosen from within the company, and outside directors, selected externally and held independent of IsoRay. The board's role is to monitor IsoRay's management team and ensure that shareholders' interests are well served. IsoRay's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, IsoRay's outside directors are responsible for providing unbiased perspectives on the board's policies.
Mark Austin, Principal Accounting Officer, Co-Principal Financial Officer, Controller | ||
Alan Hoffmann, Independent Director | ||
Lisa Lauer, Vice President - Business Development | ||
Lori Woods, Interim Chief Executive Officer, Director | ||
Michael McCormick, Independent Chairman of the Board | ||
Jonathan Hunt, Chief Financial Officer, Co-Principal Financial Officer | ||
William Cavanagh, Vice President - Research and Development | ||
Lori HolmesWoods, CEO Director | ||
Michael Krachon, Vice President, Director of Sales and Marketing | ||
Jennifer Streeter, Interim Chief Operating Officer, Vice President of Human Resources | ||
Mark CPA, Controller, Fin | ||
William III, Chief Officer | ||
Philip Vitale, Independent Director | ||
Krista Cline, Senior Director of Operations, Corporate Secretary |
IsoRay Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is IsoRay a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -0.17 | |||
Return On Asset | -0.11 | |||
Profit Margin | (1.16) % | |||
Operating Margin | (1.21) % | |||
Current Valuation | (11.02 M) | |||
Shares Outstanding | 278.66 M | |||
Shares Owned By Insiders | 0.76 % | |||
Shares Owned By Institutions | 6.18 % | |||
Number Of Shares Shorted | 409.25 K | |||
Price To Earning | (5.00) X |
Pair Trading with IsoRay
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if IsoRay position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IsoRay will appreciate offsetting losses from the drop in the long position's value.Moving against IsoRay Stock
0.71 | KB | KB Financial Group | PairCorr |
0.63 | TOEYF | Toro Energy Limited | PairCorr |
0.5 | ZION | Zions Bancorporation Normal Trading | PairCorr |
The ability to find closely correlated positions to IsoRay could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace IsoRay when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back IsoRay - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling IsoRay Inc to buy it.
The correlation of IsoRay is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as IsoRay moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if IsoRay Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for IsoRay can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Consideration for investing in IsoRay Stock
If you are still planning to invest in IsoRay Inc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the IsoRay's history and understand the potential risks before investing.
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
FinTech Suite Use AI to screen and filter profitable investment opportunities |